[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:breast-atypical-hyperplasia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Breast Atypical Hyperplasia",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05941520","Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:17:39.048487Z","2026-07-19T19:36:05.126907Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06195306","Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction",[11],"2026-08-26T02:18:31.164304Z","2026-05-05T02:43:26.724920Z",[],[]]